Diabetic Nephropathy

Diabetic Nephropathy is the indication for 16 drugs in DrugBank. It is covered by 24 curated, structured indications.

Also known as: Diabetic Nephropathies · Diabetic Nephropatia
Classified under: Digestive System Diseases
Endocrine System Diseases
Nutritional and Metabolic Diseases
Urogenital Diseases
Indicated drugs: Benazepril
Canagliflozin
Candesartan cilexetil
Captopril
Enalapril
Enalaprilat
Eprosartan
Irbesartan
Lisinopril
Losartan
Olmesartan
Perindopril
Quinapril
Ramipril
Telmisartan
Valsartan

Resolves to

Vocabularies

MeSHM0006160SNOMED CT127013003MedDRA10012638UMLSC0011881

What you can answer from here — as of October 22, 2026

16Indicated drugsWith each drug's targets and mechanism

Listed above

24Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

352Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Diabetic Nephropathy share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.